Publisher: Karger
E-ISSN: 1422-6421|164|2|82-89
ISSN: 1422-6405
Source: Cells Tissues Organs, Vol.164, Iss.2, 1999-04, pp. : 82-89
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Early heart development is known to be sensitive to retinoid concentrations. Although the influence of retinoids on cardiac morphogenesis has been described previously, the effect of retinoids on cardiomyocyte differentiation during development has not been characterized. We quantified the effects of the retinoic acids all-trans RA and 13-cis RA on α-actin and α-actinin at the subcellular level in cultures of chick embryo cardiomyocytes obtained from Hamburger and Hamilton’s (HH) stage 22, 32 and 40 embryos. The retinoids increased the concentration of α-actin and α-actinin in the cytoplasmic and cytoskeletal fractions of cells at all three stages of development. The effect was greatest in cardiomyocytes treated for 24 h with all-trans RA and in cells from HH22 embryos. The greatest increases in α-actin concentration occurred in the cytoskeletal fraction of HH22 cells cultured for 24 h with all-trans or 13-cis RA, whereas the greatest increases in α-actinin were found in the cytoplasmic fraction of HH22 cells exposed to retinoids for 24 h. We conclude that retinoic acid plays a role in the reorganization of the pattern of sarcomeric protein expression during cardiomyocyte differentiation.
Related content
By Gui Yaoting Cai Zhiming Silha Josef V. Murphy Liam J.
Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 8-9, 2006-08 ,pp. :
By Ramya D. Siddikuzzaman Grace V. M. Berlin
Immunopharmacology and Immunotoxicology, Vol. 34, Iss. 6, 2012-12 ,pp. :
Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 8, 2013-03 ,pp. :
Albumin and α1-acid glycoprotein: old acquaintances
By Filip Zemek
Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. :
α-Lipoic acid, an anti-obesity agent?
Expert Opinion on Investigational Drugs, Vol. 13, Iss. 12, 2004-12 ,pp. :